Related Experiment Video
Updated: Aug 27, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Host and viral proteins involved in SARS-CoV-2 infection differentially bind heme
Marie-T Hopp1, Dhruv C Rathod1, Diana Imhof1
1Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, Bonn, Germany.
Insights
Severe COVID-19 can cause autoimmune reactions and hemolysis. This study shows heme from red blood cells binds to SARS-CoV-2 proteins, potentially worsening the disease and highlighting the need to consider heme in COVID-19 patients.
Area of Science:
- Biochemistry
- Virology
- Immunology
Background:
- SARS-CoV-2 infection can trigger autoimmune hemolytic complications.
- Heme released during hemolysis promotes inflammation and coagulation, potentially worsening COVID-19.
- The SARS-CoV-2 accessory protein 7a is implicated in inducing proinflammatory signals.
Purpose of the Study:
- To experimentally investigate heme binding to key SARS-CoV-2 viral proteins (spike glycoprotein, protein 7a) and the host protein ACE2.
- To analyze the binding characteristics and affinities of heme to these proteins.
- To confirm the relevance of heme-binding motifs in the context of COVID-19 pathogenesis.
Main Methods:
- Chemical synthesis of SARS-CoV-2 protein 7a, including analysis of disulfide-bonded isomers.
- Surface plasmon resonance spectroscopy to assess binding kinetics and affinities.
- In silico studies to complement experimental findings.
Main Results:
- Experimental evidence confirms heme binding to SARS-CoV-2 spike glycoprotein, protein 7a, and ACE2.
- A transient, biphasic binding behavior was observed for heme.
- Heme-binding affinities were determined to be in the nano- to low micromolar range.
Conclusions:
- The findings confirm previously suggested heme-binding motifs on SARS-CoV-2 proteins.
- Labile heme should be considered in patients with pre-existing or SARS-CoV-2-induced hemolytic conditions.
- Understanding heme-protein interactions may offer new insights into COVID-19 severity and treatment.
Abstract:
In most severe cases, SARS-CoV-2-induced autoimmune reactions have been associated with hemolytic complications. Hemolysis-derived heme from ruptured red blood cells has been shown to trigger a variety of fatal proinflammatory and procoagulant effects, which might deteriorate the progression of COVID-19. In addition, the virus itself can induce proinflammatory signals via the accessory protein 7a. Direct heme binding to the SARS-CoV-2 protein 7a ectodomain and other COVID-19-related proteins has been suggested earlier. Here, we report the experimental analysis of heme binding to the viral proteins spike glycoprotein, protein 7a as well as the host protein ACE2. Thus, protein 7a chemical synthesis was established, including an in-depth analysis of the three different disulfide-bonded isomers. Surface plasmon resonance spectroscopy and in silico studies confirm a transient, biphasic binding behavior, and heme-binding affinities in the nano- to low micromolar range. These results confirm the presence of the earlier identified heme-binding motifs and emphasize the relevance for consideration of labile heme in preexisting or SARS-CoV-2-induced hemolytic conditions in COVID-19 patients.
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Viruses with RNA Genomes
Leaky Scanning
Viral Structure
Size and Structure of Viral Genomes
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

